Viking Therapeutics (VKTX) Research & Development: 2014-2025
Historic Research & Development for Viking Therapeutics (VKTX) over the last 12 years, with Sep 2025 value amounting to $90.0 million.
- Viking Therapeutics' Research & Development rose 294.79% to $90.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $222.5 million, marking a year-over-year increase of 144.06%. This contributed to the annual value of $101.6 million for FY2024, which is 59.30% up from last year.
- Viking Therapeutics' Research & Development amounted to $90.0 million in Q3 2025, which was up 49.54% from $60.2 million recorded in Q2 2025.
- Over the past 5 years, Viking Therapeutics' Research & Development peaked at $90.0 million during Q3 2025, and registered a low of $9.8 million during Q4 2021.
- In the last 3 years, Viking Therapeutics' Research & Development had a median value of $23.8 million in 2024 and averaged $32.4 million.
- Per our database at Business Quant, Viking Therapeutics' Research & Development declined by 12.32% in 2023 and then surged by 294.79% in 2025.
- Over the past 5 years, Viking Therapeutics' Research & Development (Quarterly) stood at $9.8 million in 2021, then skyrocketed by 64.29% to $16.2 million in 2022, then rose by 26.73% to $20.5 million in 2023, then surged by 51.14% to $31.0 million in 2024, then spiked by 294.79% to $90.0 million in 2025.
- Its last three reported values are $90.0 million in Q3 2025, $60.2 million for Q2 2025, and $41.4 million during Q1 2025.